Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer for you to read. Along with our medical data and news we also list Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Companies for you to search.
SummaryAnchiano Therapeutics Ltd Anchiano formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancerrelated diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancrea...
Doctors and other caregivers have a new weapon to combat the opioid epidemic. But it’s not a pharmaceutical drug—it’s a mobile app. This week, the FDA cleared “reSET-O,” an app developed by “digital therapeutics” startup Pear Therapeutics, for sale in the U.S. as a treatment for patients recovering from opioid abuse disorder. Doctors can now […]
When households in sub-Saharan Africa don't have an adequate number of insecticide-treated bed nets, pregnant women and children under five are the most likely family members to sleep under the ones they have, leaving men and school-aged children more exposed to malaria, new Johns Hopkins Center for Communication Programs research suggests.
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) — Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously announced underwritten public offering of 13,333,334 shares of its common … Continue reading →
Mentors, sponsors, coaches, role models – how will you build your personal Board of Directors? - Dr. Freda Lewis-Hall talks steps women leaders can take to effect change @Politico's #RuleWithUspic.twitter.com/6uLSX8pACy
Mentors, sponsors, coaches, role models – how will you build your personal Board of Directors? - Dr. Freda Lewis-Hall talks steps women leaders can take to effect change @Politico's #RuleWithUs pic.twitter.com/6uLSX8pACy
Micronutrients, Macronutrients and Dietary Patterns: Nutrition and Fertility Reporter: Aviva Lev-Ari, PhD, RN Folic acid. Folic acid is important for germ cell production and pregnancy. The recommended daily dose to prevent neural tube defects is 400-800 µg. Women who take folic acid-containing multivitamins are less likely to be anovulatory, and the time to achieve a pregnancy is reduced. [...
NewsArtificial intelligence has now been used to detect signs of ovulation in a woman's saliva automatically, at low cost.Contributed Author:&
Although female authorship in cardiology journals is improving, women continue to be underrepresented in research publications—particularly as first and senior authors, according to an analysis in Circulation: Cardiovascular Quality and Outcomes.
Detection of abnormalities of fetal growth or amniotic fluid was more likely in women who underwent serial third-trimester sonography; but this difference needs further interpretation.
SummaryImmunoCellular Therapeutics Ltd IMCU is a clinicalstage biotechnology company which develops immunebased therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU's immunotherapies product pipeline comprises ICT107, ICT140 and ICT121. ICT107, the lead product candidate of the company is being ...
Aravive (Nasdaq:ARAV), a clinical-stage biopharmaceutical company, today announced that the company has begun treating patients in the Phase 1b portion of a Phase 1b/Phase 2 trial combining AVB-S6-500 with standard-of-care therapies in patients with platinum-resistant recurrent ovarian cancer. As quoted in the press release: “We are excited to have begun enrollment in this clinical trial …...
(MedPage Today) -- Black women ages 65 to 74 show same stroke risk as black men
SummarySpinal Elements Inc Spinal Elements, formerly Quantum Orthopedics Inc, a subsidiary of Spinal Elements, is a medical device manufacturing company that manufactures spinal implants and instruments. The company provides products such as cervical implant systems, anterior cervical plate systems, cervical interbody systems, and posterior cervicalthoracic fixation systems, among others. It also ...
TUESDAY, Dec. 11, 2018 -- Younger breast cancer survivors are at increased risk for osteoporosis -- weak, brittle bones -- due to breast cancer treatments, new study finds. The study included 211 women who had been diagnosed with breast cancer...
1. The authors of the study concluded that parous women may have an elevated breast cancer risk for over 20 years following delivery. 2. The increased risk for breast cancer in parous women compared to nulliparous women was greatest at 5 years postpartum. Evidence Rating Level: 1 (Excellent) Study Rundown: Breast cancer is an increasingly […]
CoverGirl's Full Spectrum collection featu
An analysis of golfing patterns of physicians shows that men log more golfing hours than women and that some specialties are more likely to play than others. Medscape Medical News
Given the opioid crisis in America, surgical protocols that minimize opioid consumption are highly sought after. A recently published study shows that elimination of the tourniquet during TKA may be one such protocol. CAMARILLO, Calif. (PRWEB) December 11, 2018 A new clinical study published in the Journal of Arthroplasty comparing total knee replacement (TKR) surgery with and without use of the...
Nationally recognized expert in health technology and information exchanges to lead North America programs and services HIMSS, a global advisor and thought leader in health information and technology, announced today that Denise W. Hines, DHA, PMP, FHIMSS will join its Executive Leadership Team as Chief Americas Officer (CAO) in January. With nearly 25...
Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Nicholas C. Sacco as Chief Operating Officer. Mr. Sacco comes to ESP with 18 years of leadership experience at Sheridan Healthcare Inc., a provider of comprehensive outsourced physician practice management services to hospital systems...
Immunotherapy has proved effective in treating a number of cancers, but brain tumours have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumour arising in patients affected by neurofibromatosis type 1 (NF1) may be...
Women have seen deficits and gains in their attempts to be included in clinical research and as 2019 approaches, equality seems forthcoming.
Last month, at the 2018 American Medical Association Interim Meeting, the American Medical Association (AMA) House of Delegates passed and adopted the report “Pediatric Decision Making,” formerly entitled “Supporting Autonomy for Patients with Differences of Development (DSD).” The new rules protect the ability of doctors to provide pediat...
A recent study in JAMA Oncology compared survival for various multi-modality approaches for treating aggressive prostate cancer.
Itâs been 25 years since the NIH Revitalization Act, yet, the industry is only now approaching parity in clinical research, says researcher.